Fisetin, a naturally occurring flavonoid, is being investigated across several therapeutic areas, though clinical evidence remains limited with most research still in early phases.

Aging and Cellular Senescence

The most advanced clinical research focuses on fisetin's potential as a senolytic agent. A Phase 2 trial (NCT03430037) is currently enrolling older women to evaluate fisetin's effects on frailty, inflammation, and related age-associated measures. This builds on laboratory evidence suggesting fisetin may help clear senescent cells that accumulate with aging.

A COVID-19 pilot study in nursing home residents (NCT04537299) was terminated, limiting insights into fisetin's potential protective effects in vulnerable older populations during viral infections.

Osteoarthritis and Joint Health

Several planned studies aimed to investigate fisetin for osteoarthritis, though these have faced implementation challenges. Trials examining fisetin's effects on knee osteoarthritis pain and function (NCT05482672, NCT05505747) and its potential senolytic effects in osteoarthritis (NCT05276895) have been withdrawn or suspended. The rationale for these studies stems from preclinical evidence suggesting fisetin may reduce joint inflammation and cartilage degradation.

Cancer Research

Laboratory studies are exploring fisetin's anti-cancer properties across multiple cancer types. Recent research has investigated:

Lung cancer: Combination therapies using fisetin with other compounds in nanoparticle delivery systems for non-small cell lung cancer
Breast cancer: Studies examining how fisetin-containing nanoparticles may arrest cancer cell proliferation
Colorectal cancer: Investigation of fisetin among other plant-derived polyphenols for potential therapeutic effects

However, no clinical trials in cancer patients have been identified in the current evidence.

Neurological Conditions

Preclinical research suggests fisetin may benefit neurodegenerative disorders through multiple mechanisms including reducing neuroinflammation, oxidative stress, and supporting cellular cleanup processes. Studies have specifically examined potential applications in amyotrophic lateral sclerosis (ALS), though clinical trials in neurological conditions are not yet underway.

Liver Protection

Laboratory studies indicate fisetin may protect against liver injury through modulation of specific cellular pathways, though clinical applications have not been tested.

Current Limitations

The clinical evidence for fisetin remains quite limited. Most ongoing or planned human studies are in early phases or have faced implementation challenges. While preclinical research shows promise across multiple conditions, robust clinical data demonstrating efficacy and optimal dosing in humans is still needed.

This information is for educational purposes only and should not be considered medical advice. Consult healthcare providers before using fisetin or any supplement for medical conditions.

Fisetin